On June 20, 2025, SilverBox Corp IV announced a definitive agreement involving Parataxis Holdings to acquire a controlling interest in Bridge Biotherapeutics, which is focused on establishing a Bitcoin treasury company in South Korea. The event reflects a strategic business combination as previously outlined in a non-binding letter of intent dated June 9, 2025.